Funding for this research was provided by:
National Cancer Institute (R01NCI201487)
National Institutes of Health (R21HD085691)
Received: 23 April 2020
Accepted: 27 October 2020
First Online: 4 November 2020
Ethics approval and consent to participate
: Approval was obtained from the Committee for the Protection of Human Subjects at UT Health. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. Written informed consent was obtained from the parents.
: Additional informed consent was obtained from the patient’s parents for whom identifying information is included in this article.
: ES and JR declare financial interest in NIRF, a company seeking to commercialize NIRFLI.